Psy83 - Impact of Dose Escalation on Average Cost and Cost-Effectiveness of Anti-TNF and Ustekinumab in the Treatment of Moderate-To-Severe Plaque Psoriasis in Sweden

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.2658
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV


Related search